Sign Out
Severe Allergic Reaction: Do not administer VARIVAX to individuals with a history of anaphylactic or severe allergic reaction to any component of the vaccine (including neomycin and gelatin) or to a previous dose of a varicella-containing vaccine.
Immunosuppression: Do not administer VARIVAX to individuals who are immunodeficient or immunosuppressed due to disease or medical therapy.
Disseminated varicella disease and extensive vaccine-associated rash have been reported in individuals who are immunosuppressed or immunodeficient who were inadvertently vaccinated with a varicella-containing vaccine.
Moderate or Severe Febrile Illness: Do not administer VARIVAX to individuals with an active febrile illness with fever >101.3°F (>38.5°C).
Active Untreated Tuberculosis: Do not administer VARIVAX to individuals with active, untreated tuberculosis (TB).
Use in Pregnancy: Do not administer VARIVAX to individuals who are pregnant or planning on becoming pregnant in the next 3 months. Wild-type varicella is known to cause fetal harm [see Pregnancy under Use in Pregnancy & Lactation and Patient Counseling Information].
